Drug Shortage Report for ADDERALL XR

Last updated on 2019-03-09 History
Report ID 77992
Drug Identification Number 02248811
Brand name ADDERALL XR
Common or Proper name Mixed salts amphetamine
Company Name SHIRE PHARMA CANADA ULC
Active Ingredient(s) DEXTROAMPHETAMINE SACCHARATE DEXTROAMPHETAMINE SULFATE AMPHETAMINE ASPARTATE MONOHYDRATE AMPHETAMINE SULFATE
Strength(s) 5.00MG 5.00MG 5.00MG 5.00MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-03-07
Actual start date 2019-03-05
Estimated end date 2019-03-08
Actual end date 2019-03-08
Shortage status Resolved
Updated date 2019-03-09
Company comments
Health Canada comments
Contact Address 22 ADELAIDE ST WEST, SUITE 3800
TORONTO, ONTARIO
CANADA M5H 4E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2019-03-09 English Compare
v7 2019-03-08 French Compare
v6 2019-03-08 English Compare
v5 2019-03-07 French Compare
v4 2019-03-07 English Compare
v3 2019-03-07 French Compare
v2 2019-03-07 French Compare
v1 2019-03-07 English Compare